|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Overexpression and ahered glycosylation of MUC1 in malignant mesothelioma 显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 2 | Kinetics of the oxidative dehydrogenation of butene to butadiene over a ferrite catalyst 显示文摘 | Sterrett J S Mcllvried H G | 1974 | Ind Eng Chem Process Des Dev1974，13，1： | 1 |
| 3 | Overexpression and al- tered glyeosylation of MUCI in malignant mesothelioma 显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 4 | Bronchioloalveolar carcinoma arising in longstanding lung cysts 显示文摘 | Prichard MG Brown P J Sterrett GF | 1986 | Thorax1986，40，： | 1 |
| 5 | Overexpression and altered glycosylation of MUC1 in malignant mesothelioma显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 6 | Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States显示文摘BACKGROUND Helicobacter pylori(H.pylori),a bacterium that infects approximately half of the world’s population,is associated with various gastrointestinal diseases,including peptic ulcers,non-ulcer dyspepsia,gastric adenocarcinoma,and gastric lymphoma.As the burden of antibiotic resistance increases,the need for new adjunct therapies designed to facilitate H.pylori eradication and reduce negative distal outcomes associated with infection has become more pressing.Characterization of the interactions between H.pylori,the fecal microbiome,and fecal fatty acid metabolism,as well as the mechanisms underlying these interactions,may offer new therapeutic approaches.AIM To characterize the gut microbiome and metabolome in H.pylori patients in a socioeconomically challenged and underprivileged inner-city community.METHODS Stool samples from 19 H.pylori patients and 16 control subjects were analyzed.16S rRNA gene sequencing was performed on normalized pooled amplicons using the Illumina MiSeq System using a MiSeq reagent kit v2.Alpha and beta diversity analyses were performed in QIIME 2.Non-targeted fatty acid analysis of the samples was carried out using gas chromatography-mass spectrometry,which measures the total content of 30 fatty acids in stool after conversion into their corresponding fatty acid methyl esters.Multi-dimensional scaling(MDS)was performed on Bray-Curtis distance matrices created from both the metabolomics and microbiome datasets and a Procrustes test was performed on the metabolomics and microbiome MDS coordinates.RESULTS Fecal microbiome analysis showed that alpha diversity was lowest in H.pylori patients over 40 years of age compared to control subjects of similar age group.Beta diversity analysis of the samples revealed significant differences in microbial community structure between H.pylori patients and control subjects across all ages.Thirty-eight and six taxa had lower and higher relative abundance in H.pylori patients,respectively.Taxa that were enriched in H.pylori patients included Atopobium,Gemellaceae,Micrococcaceae,Gemellales and Rothia(R.mucilaginosa).Notably,relative abundance of the phylum Verrucomicrobia was decreased in H.pylori patients compared to control subjects.Procrustes analysis showed a significant relationship between the microbiome and metabolome datasets.Stool samples from H.pylori patients showed increases in several fatty acids including the polyunsaturated fatty acids(PUFAs)22:4n6,22:5n3,20:3n6 and 22:2n6,while decreases were noted in other fatty acids including the PUFA 18:3n6.The pattern of changes in fatty acid concentration correlated to the Bacteroidetes:Firmicutes ratio determined by 16S rRNA gene analysis.CONCLUSION This exploratory study demonstrates H.pylori-associated changes to the fecal microbiome and fecal fatty acid metabolism.Such changes may have implications for improving eradication rates and minimizing associated negative distal outcomes. | Brian White John D Sterrett Zoya Grigoryan Lauren Lally Jared D Heinze Hyder Alikhan Christopher A Lowry Lark J Perez Joshua DeSipio Sangita Phadtare | 2021 | World Journal of Gastroenterology2021，27，33： | 1 |
| 7 | Transloeation and degradation of injected uniconazole in apple during a 4-month growing period显示文摘 | Sterrett J P | 1990 | Journal of Phmt Regulation1990，，9： | 1 |
| 8 | Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate显示文摘 | STERRETT S P PENNISTON K L WOLF J S Jr | 2008 | Urology2008，72，2： | 1 |
| 9 | Over-expression and altered glycosylation of MUC1 in malignant mesothelioma 显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 10 | Overexpresaion and altered glycosylation of MUCI in malignant mesothelioma显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 11 | Clinical outcomes using aggressive approach tO anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia 显示文摘 | Shah AP Klein A J Sterrett A | 2009 | Catheter Cardiovasc Interv2009，74，： | 1 |
| 12 | Overexpression and altered gtycosylation of MUC1 in malignant mesothelioma 显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 13 | Overexpression and altered glycosylation of MUC1 in malignant mesothelioma显示文摘 | Creaney J Segal A Sterrett G | 2008 | Br J Cancer2008，98，9： | 1 |
| 14 | Effects of home bleaching on the tissues of the oral cavity显示文摘 | Sterrett J Price RB Bankey T | 1995 | J Can Dent Assoc1995，61，5： | 1 |
| 15 | Cinacalcet HCI(Sensipar/Mimpara)is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism显示文摘 | Sterrett JR Strom J Stummvoll HK | 2007 | Clin Nephrol2007，68，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员